The Moderna, Inc. (MRNA) revenue growth is (52.9%), which is lower than the industry median of 12.6% and the 5-year historical average of 2,164.1%.
The Moderna, Inc. (MRNA) operating income growth is (6.9%), compared to the industry median of 10.6% and the 5-year historical average of 225.5%.
The Moderna, Inc. (MRNA) EPS growth is (25.0%), compared to the industry median of (19.3%) and the 5-year historical average of 207.3%.
The Moderna, Inc. (MRNA) Free Cash Flow growth is 13.9%, compared to the industry median of (3.4%) and the 5-year historical average of 229.4%.